These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17158788)

  • 1. ECNIS-sponsored workshop on biomarkers of exposure and cancer risk: DNA damage and DNA adduct detection and 6th GUM-32P-postlabelling workshop, German Cancer Research Center, Heidelberg, Germany, 29-30 September 2006.
    Arlt VM; Frei E; Schmeiser HH
    Mutagenesis; 2007 Jan; 22(1):83-8. PubMed ID: 17158788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exposure biomarkers for the study of toxicological impact on carcinogenic processes.
    Farmer PB
    IARC Sci Publ; 2004; (157):71-90. PubMed ID: 15055291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UKEMS/Dutch EMS-sponsored workshop on biomarkers of exposure and oxidative DNA damage & 7th GUM-32P-postlabelling workshop, University of Münster, Münster, Germany, 28-29 March 2011.
    Arlt VM; Schwerdtle T
    Mutagenesis; 2011 Sep; 26(5):679-85. PubMed ID: 21693685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human biomonitoring: state of the art.
    Angerer J; Ewers U; Wilhelm M
    Int J Hyg Environ Health; 2007 May; 210(3-4):201-28. PubMed ID: 17376741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies using specific biomarkers for human exposure assessment to exogenous and endogenous chemical agents.
    Farmer PB
    Mutat Res; 1999 Jul; 428(1-2):69-81. PubMed ID: 10517980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toxicological significance of DNA adducts: summary of discussions with an expert panel.
    Nestmann ER; Bryant DW; Carr CJ
    Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):9-18. PubMed ID: 8921541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The uses of carcinogen-DNA adduct measurement in establishing mechanisms of mutagenesis and in chemoprevention.
    Baird WM; Mahadevan B
    Mutat Res; 2004 Mar; 547(1-2):1-4. PubMed ID: 15013693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of a workshop on DNA adducts: biological significance and applications to risk assessment Washington, DC, April 13-14, 2004.
    Sander M; Cadet J; Casciano DA; Galloway SM; Marnett LJ; Novak RF; Pettit SD; Preston RJ; Skare JA; Williams GM; Van Houten B; Gollapudi BB
    Toxicol Appl Pharmacol; 2005 Oct; 208(1):1-20. PubMed ID: 16164957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between biomarkers of human exposure to genotoxins with focus on carcinogen-DNA adducts.
    Gyorffy E; Anna L; Kovács K; Rudnai P; Schoket B
    Mutagenesis; 2008 Jan; 23(1):1-18. PubMed ID: 17989146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility.
    Badawi AF; Stern SJ; Lang NP; Kadlubar FF
    Prog Clin Biol Res; 1996; 395():109-40. PubMed ID: 8895986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular dosimetry of DNA damage induced by polycyclic aromatic hydrocarbons; relevance for exposure monitoring and risk assessment.
    Baan RA; Steenwinkel MJ; van den Berg PT; Roggeband R; van Delft JH
    Hum Exp Toxicol; 1994 Dec; 13(12):880-7. PubMed ID: 7718309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of DNA adducts in humans after complex mixture exposure.
    Dale CM; Garner RC
    Food Chem Toxicol; 1996 Sep; 34(9):905-19. PubMed ID: 8972883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human DNA adduct measurements: state of the art.
    Poirier MC; Weston A
    Environ Health Perspect; 1996 Oct; 104 Suppl 5(Suppl 5):883-93. PubMed ID: 8933030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined micropreparative techniques with synchronous fluorescence spectroscopy or 32P-postlabelling assay for carcinogen-DNA adduct determination.
    Shields PG; Kato S; Bowman ED; Petruzzelli S; Cooper DP; Povey AC; Weston A
    IARC Sci Publ; 1993; (124):243-54. PubMed ID: 8225491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA adducts as exposure biomarkers and indicators of cancer risk.
    Poirier MC
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):907-12. PubMed ID: 9255579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA adducts in biomonitoring.
    Hemminki K
    J Occup Environ Med; 1995 Jan; 37(1):44-9. PubMed ID: 7620942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carcinogen macromolecular adducts and their measurement.
    Poirier MC; Santella RM; Weston A
    Carcinogenesis; 2000 Mar; 21(3):353-9. PubMed ID: 10688855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogen-DNA adducts as tools in risk assessment.
    Airoldi L; Pastorelli R; Magagnotti C; Fanelli R
    Adv Exp Med Biol; 1999; 472():231-40. PubMed ID: 10736630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of non-invasive biomarkers for carcinogen-DNA adduct analysis in occupationally exposed populations.
    Talaska G; Cudnik J; Jaeger M; Rothman N; Hayes R; Bhatnagar VJ; Kayshup SJ
    Toxicology; 1996 Jul; 111(1-3):207-12. PubMed ID: 8711736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA adducts in tumour, normal peripheral lung and bronchus, and peripheral blood lymphocytes from smoking and non-smoking lung cancer patients: correlations between tissues and detection by 32P-postlabelling and immunoassay.
    Gyorffy E; Anna L; Gyori Z; Segesdi J; Minárovits J; Soltész I; Kostic S; Csekeo A; Poirier MC; Schoket B
    Carcinogenesis; 2004 Jul; 25(7):1201-9. PubMed ID: 15001535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.